Results 181 to 190 of about 355,709 (346)

F-18 FDG PET and its potential in therapeutic management and 3D-radiation treatment planning of non-small cell lung cancer (NSCLC) [PDF]

, 2002
M Schmuecking, Richard P. Baum, R. Bonnet, N. Presselt, Christian Przetak, Piotr J. Slomka, Klaus Junker, J. Leonhardi, CP Schneider, Klaus Hoeffken, Th. Wendt   +10 more
openalex   +1 more source

Population Pharmacokinetics and Exposure‐Response Analysis of First‐Line Osimertinib Plus Chemotherapy in Patients with EGFR‐Mutated Advanced NSCLC

Clinical Pharmacology &Therapeutics, EarlyView.
Osimertinib, a third‐generation, central nervous system‐active epidermal growth factor receptor‐tyrosine kinase inhibitor, potently and selectively inhibits epidermal growth factor receptor‐tyrosine kinase inhibitor sensitizing and T790M resistance mutations, with efficacy in epidermal growth factor receptor‐mutated non‐small cell lung cancer.
Jincheng Yang, Damilola Olabode, Aarti Sawant‐Basak, Richard Baldry, Karthick Vishwanathan, Srinivas Bachina, Alexandar Todd, Dana Ghiorghiu, Yuri Rukazenkov, Diansong Zhou, Azar Shahraz   +10 more
wiley   +1 more source

PCN1O: PSYCHOMETRIC VALIDITY OF QUALITY OF LIFE AND UTILITY MEASURES IN NON-SMALL CELL LUNG CANCER (NSCLC): A LITERATURE REVIEW

, 2000
MP Emery, Kikelomo T. Adesina, Patrick Marquis, R. Van Gool   +3 more
openalex   +1 more source

Decision analysis in NSCLC [PDF]

, 2002
Fergus Macbeth
openalex   +1 more source

Hsa_circ_0071271 affected the progression of non-small cell lung cancer through miR-23a-5p. [PDF]

Hereditas
Wu Y, Zhang L, Li W, Yan D, Yue J, Liu Z.   +5 more
europepmc   +1 more source

Autophagy‐Targeting Nanomedicine: Strike at the Heart of the Cancer via Precise Modulation of Autophagy

Exploration, EarlyView.
This review emphasizes the critical role of autophagy in cancer treatment, highlighting the development of autophagy‐targeting nanomedicines and their applications in combination therapies. It explores how nanoplatforms can effectively regulate autophagy, underscoring the potential of integrating autophagy modulation with other treatment strategies to ...
Zhouyi Sun, Huali Zuo, Kai Zhang, Yang Liu, Qianwen Wang, Qitao Hu, Jiwei Qian, Andreas Lundqvist, Bo Zhang, Weiyu Chen, Zhe Tang   +10 more
wiley   +1 more source

Lactic acid promotes non-small cell lung cancer progression by down-regulating hexokinase 1 via histone lactylation: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Wang Y, Zhao J, Han K.
europepmc   +1 more source

Natural Products Targeting the EGFR/HER2 Axis in Tumorigenesis: Interpretation of Molecular Mechanisms and Recent Insights Into Synergistic Strategies for Cancer Therapy

Food Frontiers, EarlyView.
Schematic overview illustrating the anticancer mechanisms of selected natural products (resveratrol, quercetin, berberine) targeting EGFR and HER2 signaling pathways in tumor cells. These compounds inhibit receptor activation and downstream oncogenic cascades, including PI3K/Akt/mTOR, MAPK/ERK, and STAT3 pathways.
Iman Ramli, Anna Maria Posadino, Roberta Giordo, Antonio Barberis, Ylenia Spissu, Redouane Lemoui, William N. Setzer, Javad Sharifi‐Rad, Gianfranco Pintus   +8 more
wiley   +1 more source

Identification of C4BPA as a genetically informed drug target in NSCLC: an integrative single-cell and multi-omics study based on the druggable genes. [PDF]

Hum Genomics
Xiao Z, Liu X, Tang W, Lv Y, Zhang T, Zhan X, Sun Q, Omindo WW, Wang Q, Zhang R, Ping W, Zhang N.   +11 more
europepmc   +1 more source

Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients¹ [PDF]

, 2003
Hirokazu Watanabe, Seiichiro Yamamoto, Hideo Kunitoh, Ikuo Sekine, Noboru Yamamoto, Yuichiro Ohe, Tomohide Tamura, Tetsuro Kodama, Kazuro Sugimura, Nagahiro Saijo   +9 more
openalex   +1 more source